• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

14

CATEGORIES

  • 12
  • 11
  • 11
  • 8
  • 7
  • 5
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

7
16
22
68

PUBLISHED

0
7
34
68

PRODUCT TYPE

56
12

Search "MultiCell Technologies Inc.-Therapeutic Competitors" returned 68 results.

PRODUCT TITLE

MultiCell Technologies, Inc. (MCET) - Financial and Strategic SWOT Analysis Review

MultiCell Technologies, Inc. (MCET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

July 2014
FROM
Regenerative Medicine - Global Strategic Business Report Regenerative Medicine - Global Strategic Business Report - Product Thumbnail Image

Regenerative Medicine - Global Strategic Business Report

This report analyzes the worldwide markets for Regenerative Medicine in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, Asia-Pacific, and Rest of World....

June 2014
FROM

Osiris Therapeutics, Inc. (OSIR) - Financial and Strategic SWOT Analysis Review

Osiris Therapeutics, Inc. (OSIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

April 2014
FROM
Competitor Analysis: Her2 and Her3 Receptor Antagonists Competitor Analysis: Her2 and Her3 Receptor Antagonists - Product Thumbnail Image

Competitor Analysis: Her2 and Her3 Receptor Antagonists

The present Competitive Intelligence Report about Her2 and Her3 receptor antagonists provides a competitor evaluation in the field of Her2 (ErbB2) and Her3 receptor targeting molecules for treatment...

September 2011
FROM

Cancer Diagnostic Testing World Markets

Cancer testing is one of the most important growth opportunities for the next three to five years in the diagnostics segment The National Cancer Institute estimates that about ten million Americans...

May 2013
FROM
Competitor Analysis: c-MET/HGF Inhibitors Competitor Analysis: c-MET/HGF Inhibitors - Product Thumbnail Image

Competitor Analysis: c-MET/HGF Inhibitors

The Competitive Intelligence Report c-MET/HGF Inhibitors as of June 2011 provides a competitor analysis in the development pipeline of novel emerging inhibitors of c-MET receptor tyrosine kinase (RTK)...

June 2011
FROM

Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2014

Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2014 Summary This, ‘Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2014’, provides an overview of the Hematopoietic Stem...

October 2014
FROM

Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2014

Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2014’, provides an overview of the...

April 2014
FROM

Bioseparation Systems for Global Biopharmaceutical Markets

Bioseparations systems can be categorized into three types: chromatography, membranes/filters and centrifuges The demand for single use products is increasing and fueling growth of the global bioseparations...

August 2013
FROM

Athersys, Inc. (ATHX) - Financial and Strategic SWOT Analysis Review

Athersys, Inc. (ATHX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData...

June 2014
FROM
Drug-Eluting Stents - Global Business Strategic Report Drug-Eluting Stents - Global Business Strategic Report - Product Thumbnail Image

Drug-Eluting Stents - Global Business Strategic Report

This report analyzes the worldwide markets for Drug-Eluting Stents in US$ Million The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of the World Annual estimates...

May 2012
FROM

Regenerative Medicine - Global Trends, Estimates and Forecasts, 2013-2019

Global Market Watch: Global Regenerative Medicine market is estimated to reach US$24.7 billion by 2017. Regenerative Medicine in Orthopedics market is projected to reach US$10.3 billion by 2017,...

April 2015
FROM

GE Healthcare - Strategic SWOT Analysis Review

GE Healthcare - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT...

May 2014
FROM

Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015

Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015 Summary This, ‘Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015’, provides an overview of the Peripheral...

March 2015
FROM

Ischemic Stroke - Pipeline Review, H1 2015

Ischemic Stroke - Pipeline Review, H1 2015 Summary: This, ‘Ischemic Stroke - Pipeline Review, H1 2015’, provides an overview of the Ischemic Stroke’s therapeutic pipeline. This report provides...

March 2015
FROM

Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost - Effective Purification Technologies

“Down Stream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost-effective Purification Technologies”, provides the key data and analyzes the major challenges...

November 2010
FROM

Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2014

Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2014 Summary This, ‘Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2014’, provides an overview of the Congestive Heart...

October 2014
FROM

Neogenix Oncology, Inc. - Product Pipeline Analysis

Summary Neogenix Oncology, Inc. (NOI) is a clinical stage biotechnology company, based in the US. The company develops therapeutic and diagnostic products for the early detection and treatment of cancer....

November 2012
FROM

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014 Summary This, ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014’, provides an overview of the...

October 2014
FROM

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H1 2015

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H1 2015 Summary This, ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H1 2015’, provides an overview of the...

January 2015
FROM
Loading Indicator

Our Clients

Walgreen's Company Elanco Global Nu Skin Enterprises Kemin Industries, Inc. Suan Farma Inc. Metagenics, Inc.